Maravai LifeSciences Holdings, Inc. (MRVI) Total liabilities 2020–2025
Maravai LifeSciences Holdings, Inc. (MRVI) total liabilities at each fiscal year-end, per SEC filings.
$397.9MFY2025 · since FY2020: $1.1B → $397.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $397.9M | -7.7% |
| FY2024 | $431.0M | -38.2% |
| FY2023 | $697.6M | -49.3% |
| FY2022 | $1.4B | +0.3% |
| FY2021 | $1.4B | +23.0% |
| FY2020 | $1.1B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More MRVI financial trends
MRVI RevenueMRVI Net incomeMRVI Net marginMRVI Gross profitMRVI Gross marginMRVI Operating incomeMRVI Operating marginMRVI Operating cash flowMRVI Free cash flowMRVI Capital expendituresMRVI Return on equityMRVI Stock buybacksMRVI Dividends paidMRVI Total assetsMRVI Shareholders’ equityMRVI overview →